 In this 2-site clinical trial, intended to evaluate the safety and efficacy of repeated doses of ketamine for treatment resistant PTSD, Veterans and active duty military personnel who meet criteria for PTSD and the additional inclusion and exclusion criteria will be randomized to one of three treatment arms placebo, low dose ketamine, high dose ketamine. Participants receive the study drug via intravenous infusion twice per week for 4-weeks. 